Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lein

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
The Journal of Urology|March 16, 2016
Serum Vitamin D is Not Helpful for Predicting Prostate Cancer Aggressiveness Compared with the Prostate Health IndexCarsten Stephan, Michael Lein, Julia Matalon, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 16, 2004
Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer modelUlrich Siler, Luca Barella, Volker Spitzer, et al.
European Urology|December 5, 2006
Re: Felix K.-H. Chun, Markus Graefen, Alberto Briganti, Andrea Gallina, Julia Hopp, Michael W. Kattan, Hartwig Huland and Pierre I. Karakiewicz. Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. Eur Urol 2007;51:1236-43Carsten Stephan, Hellmuth-A Meyer, Henning Cammann, et al.
Cancer Chemotherapy and Pharmacology|June 8, 2006
Enhanced inhibitory effect of the matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine and etoposide on the prostate carcinoma in the rat Dunning orthotopic tumor modelClaudia Abramjuk, Michael Lein, Winfried Rothaug, et al.
Experimental & Molecular Medicine|October 5, 2010
Suitable reference genes for relative quantification of miRNA expression in prostate cancerAnnika Schaefer, Monika Jung, Kurt Miller, et al.
International Journal of Cancer|June 6, 2013
Tissue metabolite profiling identifies differentiating and prognostic biomarkers for prostate carcinomaKlaus Jung, Regina Reszka, Beate Kamlage, et al.
Urology|February 13, 2002
Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancerCarsten Stephan, Klaus Jung, Eleftherios P Diamandis, et al.
The Journal of Urology|September 6, 2006
Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinomaKlaus Jung, Michael Lein, Martin Ringsdorf, et al.
Cancer Letters|May 28, 2008
Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinomaAzizbek Ramankulov, Michael Lein, Manfred Johannsen, et al.
BJU International|June 5, 2008
An artificial neural network for five different assay systems of prostate-specific antigen in prostate cancer diagnosticsCarsten Stephan, Henning Cammann, Hellmuth-Alexander Meyer, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
The Journal of Urology|March 16, 2016
Serum Vitamin D is Not Helpful for Predicting Prostate Cancer Aggressiveness Compared with the Prostate Health IndexCarsten Stephan, Michael Lein, Julia Matalon, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 16, 2004
Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer modelUlrich Siler, Luca Barella, Volker Spitzer, et al.
European Urology|December 5, 2006
Re: Felix K.-H. Chun, Markus Graefen, Alberto Briganti, Andrea Gallina, Julia Hopp, Michael W. Kattan, Hartwig Huland and Pierre I. Karakiewicz. Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. Eur Urol 2007;51:1236-43Carsten Stephan, Hellmuth-A Meyer, Henning Cammann, et al.
Cancer Chemotherapy and Pharmacology|June 8, 2006
Enhanced inhibitory effect of the matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine and etoposide on the prostate carcinoma in the rat Dunning orthotopic tumor modelClaudia Abramjuk, Michael Lein, Winfried Rothaug, et al.
Experimental & Molecular Medicine|October 5, 2010
Suitable reference genes for relative quantification of miRNA expression in prostate cancerAnnika Schaefer, Monika Jung, Kurt Miller, et al.
International Journal of Cancer|June 6, 2013
Tissue metabolite profiling identifies differentiating and prognostic biomarkers for prostate carcinomaKlaus Jung, Regina Reszka, Beate Kamlage, et al.
Urology|February 13, 2002
Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancerCarsten Stephan, Klaus Jung, Eleftherios P Diamandis, et al.
The Journal of Urology|September 6, 2006
Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinomaKlaus Jung, Michael Lein, Martin Ringsdorf, et al.
Cancer Letters|May 28, 2008
Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinomaAzizbek Ramankulov, Michael Lein, Manfred Johannsen, et al.
BJU International|June 5, 2008
An artificial neural network for five different assay systems of prostate-specific antigen in prostate cancer diagnosticsCarsten Stephan, Henning Cammann, Hellmuth-Alexander Meyer, et al.
Pageof 11